The C611Y mutation belongs to ATA-b (moderate risk),[4] which is mainly related to MEN2A, familial medullary thyroid carcinoma (FMTC), and MEN2A with HSCR. The gene discussed is RET; the disease is multiple endocrine neoplasia type 2.